Swine Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Apr 2018

Formats :
Report Code : PMR83649588

Category : Food and Beverages
No Of Pages :
Global Swine Vaccines Market: By Vaccine Type Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others, By Disease Type Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others, By Distribution Channel Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies, and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 20132017 and Forecast 20182024

Market Outline: Swine Vaccines Market

Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a diseasecausing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.

Market Dynamics: Swine Vaccines Market
Drivers
Increase in the demand for healthy pork meat and rise in pork meat production
Rise in R&D expenditure for the innovation of newer vaccines
Rise in prevalence of various infectious diseases
Restraints
Stringent regulatory policies for the swine vaccine approval
Adverse effects such as allergies associated with the vaccines
High cost and lack of awareness about swine vaccines in underdeveloped countries

Market Scope: Swine Vaccines Market
Global swine vaccines market is segmented on the basis of vaccine type, disease type, distribution channel, and region
Based on the vaccine type, swine vaccines market is segmented into the following
Inactivated Vaccines
Recombinant vaccines
Live attenuated vaccines
DNA vaccines
Subunit vaccines
Others
Based on the disease type, swine vaccines market is segmented into the following
Viral Infections
Bacterial Infections
Parasitic Infection
Fungal Infections
Others
Based on the distribution channel, swine vaccines market is segmented into the following:
Veterinary Hospitals
Veterinary Pharmacies
Online Pharmacies
Based on the region, swine vaccines market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competition Assessment: Swine Vaccines Market
Some of the players in the global swine vaccines market include:
Zoetis Pfizer, Inc. U.S.
Merck & Co. Inc. U.S
Virbac S.A. France
Boehringer Ingelheim Vetmedica Germany
Elanco U.S.
Bayer Animal Health Germany
Ceva Sante Animale France

Notable Market Developments: Swine Vaccines Market
In June 2017, Bayer Animal Health launched Bayovac Suishot APM7 vaccine used against the respiratory diseases caused by A.pleuropneumoniae serotype 2 and 5 and Pasteurella multocida type A and D in swine

Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market 20132017 and forecast 20182024
The report covers indetail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of sociopolitical environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Swine Vaccine Market Introduction
2.1. Global Swine Vaccine Market – Taxonomy
2.2. Global Swine Vaccine Market –Definitions
2.2.1. Vaccine Type
2.2.2. Disease Type
3. Global Swine Vaccine Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Swine Vaccine Market Dynamic Factors Impact Analysis
3.6. Global Swine Vaccine Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. Global Swine Vaccine Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Opportunity Analysis
5. Global Swine Vaccine Market, By Vaccine Type, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Recombinant vaccines
5.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Live Attenuated vaccines
5.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. DNA vaccines
5.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
5.5. Subunit vaccines
5.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.6.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.6.3. Market Opportunity Analysis
6. Global Swine Vaccine Market Forecast, By Disease Type, 2013 2017 and Forecast, 2018 – 2024
6.1. Viral Infections
6.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Bacterial Infections
6.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Parasitic Infection
6.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
6.4. Parasitic Infection
6.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.5.3. Market Opportunity Analysis
7. Global Swine Vaccine Market Forecast, By Distribution Channel, 2013 2017 and Forecast, 2018 – 2024
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Veterinary Pharmacies
7.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
7.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
8. Global Swine Vaccine Market Forecast, By Region, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1. North America
8.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. AsiaPacific
8.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Region, 2018 – 2024
9. North America Swine Vaccine Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.1. Vaccine Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Inactivated Vaccines
9.1.2. Recombinant vaccines
9.1.3. Live attenuated vaccines
9.1.4. DNA vaccines
9.1.5. Subunit vaccines
9.1.6. Others
9.2. Disease Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.2.1. Viral Infections
9.2.2. Bacterial Infections
9.2.3. Parasitic Infection
9.2.4. Fungal Infections
9.2.5. Others
9.3. Distribution Channel Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.3.1. Veterinary Hospital
9.3.2. Veterinaty Pharmacies
9.3.3. Online Pharmaceis
9.4. Country Analysis 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
9.4.1. U.S.
9.4.2. Canada
9.5. North America Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2018 – 2024
9.6. North America Swine Vaccine Market Dynamics – Trends
10. Europe Swine Vaccine Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
10.1. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
10.1.1. Germany
10.1.2. UK
10.1.3. France
10.1.4. Spain
10.1.5. Italy
10.1.6. Russia
10.1.7. Poland
10.1.8. Rest of Europe
10.2. Europe Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2018 – 2024
10.3. Europe Swine Vaccine Market Dynamics – Trends
11. AsiaPacific Swine Vaccine Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
11.1. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. ASEAN
11.1.5. Australia & New Zealand
11.1.6. Rest of AsiaPacific
11.2. AsiaPacific Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2018 – 2024
11.3. AsiaPacific Swine Vaccine Market Dynamics – Trends
12. Latin America Swine Vaccine Market Analysis, 2013 2013 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
12.1. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Argentina
12.1.4. Venezuela
12.1.5. Rest of Latin America
12.2. Latin America Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2018 – 2024
12.3. Latin America Swine Vaccine Market Dynamics – Trends
13. Middle East and Africa Swine Vaccine Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
13.1. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
13.1.1. Gulf Cooperation Council GCC Countries
13.1.2. Israel
13.1.3. South Africa
13.1.4. Rest of MEA
13.2. MEA Swine Vaccine Market Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2018 – 2024
13.3. MEA Swine Vaccine Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Zoetis Pfizer, Inc. U.S.
14.2.2. Merck & Co. Inc. U.S
14.2.3. Virbac S.A. France
14.2.4. Boehringer Ingelheim Vetmedica Germany
14.2.5. Elanco U.S.
14.2.6. Bayer Animal Health Germany
14.2.7. Ceva Sante Animale France
15. Research Methodology
16. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....